Glaucoma Treatment

Glaucoma Treatment Market by Indication (Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma), Type (Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors), Sales Channel - Global Forecast 2024-2030

SKU
MRR-430D3EB72947
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 6.73 billion
2030
USD 12.27 billion
2024
USD 7.31 billion
CAGR
8.94%
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the glaucoma treatment market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[184 Pages Report] The Glaucoma Treatment Market size was estimated at USD 6.73 billion in 2023 and expected to reach USD 7.31 billion in 2024, at a CAGR 8.94% to reach USD 12.27 billion by 2030.

Glaucoma Treatment Market
To learn more about this report, request a free PDF copy
Glaucoma Treatment Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glaucoma Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glaucoma Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glaucoma Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accutome, Inc., Akorn Operating Company LLC, Alcon Vision LLC, Amorphex Therapeutics LLC, ASICO LLC, Bausch + Lomb Corporation, Bayer AG, Carl Zeiss Meditec AG, Fera Pharmaceuticals, LLC, Glaukos Corporation, Inotek Pharmaceuticals, Lumenis Be Ltd., Merck & Co, Inc., Mobius Therapeutics, LLC, NIDEK CO., LTD., Novartis AG, Ocular Therapeutix, Inc., Perrigo Company PLC, Pfizer, Inc., Quantel Medical, Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Glaucoma Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Angle Closure Glaucoma
    • Congenital Glaucoma
    • Open Angle Glaucoma
    • Secondary Glaucoma
  • Type
    • Alpha Agonist
    • Beta Blockers
    • Carbonic Anhydrase Inhibitors
    • Cholinergic
    • Combined Medications
    • Prostaglandin Analogs
  • Sales Channel
    • Hospital Pharmacies
    • Online Sales
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Glaucoma Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glaucoma Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Glaucoma Treatment Market?
  4. What is the market share of the leading vendors in the Glaucoma Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Glaucoma Treatment Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Glaucoma Treatment Market, by Indication
  7. Glaucoma Treatment Market, by Type
  8. Glaucoma Treatment Market, by Sales Channel
  9. Americas Glaucoma Treatment Market
  10. Asia-Pacific Glaucoma Treatment Market
  11. Europe, Middle East & Africa Glaucoma Treatment Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 294]
  16. List of Companies Mentioned [Total: 24]
Frequently Asked Questions
  1. How big is the Glaucoma Treatment Market?
    Ans. The Global Glaucoma Treatment Market size was estimated at USD 6.73 billion in 2023 and expected to reach USD 7.31 billion in 2024.
  2. What is the Glaucoma Treatment Market growth?
    Ans. The Global Glaucoma Treatment Market to grow USD 12.27 billion by 2030, at a CAGR of 8.94%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.